Ceftolozane/tazobactam for the treatment of bacteremia: a systematic literature review (SLR).

ABSTRACT:

Background

Bloodstream infections (BSIs), or bacteremia, are responsible for considerable disease burden. Increasing rates of antibiotic resistance and delays in selection of appropriate treatment lead to increased morbidity, mortality, and costs. Due to limitations of current standard treatments, especially for bacteremia caused by resistant pathogens, a systematic literature review (SLR) was conducted to understand the utilization of ceftolozane/tazobactam (C/T) in bacteremia.

Methods

Electronic database searches of EMBASE^®, MEDLINE^®, CCTR and Northern Lights, as well as hand searches of conference proceedings from the last two annual meetings (i.e., 2018, 2019) of the European Congress of Clinical Microbiological and Infectious Diseases (ECCMID) and

SUBMITTER: Khankhel ZS 

PROVIDER: S-EPMC9531517 | biostudies-literature | 2022 Oct

REPOSITORIES: biostudies-literature